期刊文献+

Increasing awareness of recognition of chronic obstructive pulmonary disease 被引量:8

Increasing awareness of recognition of chronic obstructive pulmonary disease
原文传递
导出
摘要 The medical community should, by now, be well aware of the importance of chronic obstructive pulmonary disease (COPD), an increasingly common condition with high morbidity and mortality. In modern terms, COPD has come to signify concurrent chronic bronchitis, asthmatic bronchitis and emphysema. Cigarette smoking has long been recognized as the predominant aetiological agent. Arterial hypoxaemia, a frequent complication of COPD, can lead to pulmonary hypertension and cor pulmonale. COPD affects over 5% of the adult population and is the only major cause of death whose morbidity and mortality are increasing in several countries. In China, it is difficult to quantify how many people are affected with COPD. However, a recent epidemiological survey indicated that COPD prevalence was 8.2% in China. COPD prevalence in men was significantly higher than in women (12.4% cf 5.1%). The prevalence in rural areas was higher than that in urban areas (8.8% cf 7.8%). Of patients with COPD, 61.5% were smokers. The report also stated that COPD is the major cause of death in rural areas in China and the fourth leading cause of death in urban areas, rising to the third leading cause of death by 2020. The prevalence of the disease increases with age with highest rates seen in people over the age of 70 years. COPD is the only major cause of mortality with a rising incidence and prevalence worldwide, rendering it an increasingly worrisome. The medical community should, by now, be well aware of the importance of chronic obstructive pulmonary disease (COPD), an increasingly common condition with high morbidity and mortality. In modern terms, COPD has come to signify concurrent chronic bronchitis, asthmatic bronchitis and emphysema. Cigarette smoking has long been recognized as the predominant aetiological agent. Arterial hypoxaemia, a frequent complication of COPD, can lead to pulmonary hypertension and cor pulmonale. COPD affects over 5% of the adult population and is the only major cause of death whose morbidity and mortality are increasing in several countries. In China, it is difficult to quantify how many people are affected with COPD. However, a recent epidemiological survey indicated that COPD prevalence was 8.2% in China. COPD prevalence in men was significantly higher than in women (12.4% cf 5.1%). The prevalence in rural areas was higher than that in urban areas (8.8% cf 7.8%). Of patients with COPD, 61.5% were smokers. The report also stated that COPD is the major cause of death in rural areas in China and the fourth leading cause of death in urban areas, rising to the third leading cause of death by 2020. The prevalence of the disease increases with age with highest rates seen in people over the age of 70 years. COPD is the only major cause of mortality with a rising incidence and prevalence worldwide, rendering it an increasingly worrisome.
作者 WANG Zeng-li
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2006年第8期669-675,共7页 中华医学杂志(英文版)
基金 This work was supported by a grant from National Natural Science Foundation of China (No. 39770340).
关键词 chronic obstructive pulmonary disease underecognition GUIDELINE MANAGEMENT chronic obstructive pulmonary disease underecognition guideline management
  • 相关文献

参考文献10

  • 1Pauwels RA,Buist AS,Calverley PM,Jenkins CR,Hurd SS.On behalf of the GOLD Scientific Committee.Global strategy for the diagnosis, management, and preventionof chronic obstructive pulmonary disease. NHLBI/WHO global inititive for GOLD workshop summary[].American Journal of Respiratory and Critical Care Medicine.2001
  • 2Fishman AP.One hundred years of chronic obstructive pulmonary disease[].American Journal of Respiratory and Critical Care Medicine.2005
  • 3Remmard SI,Schachter N,Strek M,Richard K,Amit O.Cilomilast for COPD results of a 6-month, placebo, controlled study of a potent, selective inhibator of phosohodiesterase 4[].Chest.2006
  • 4Vestbo J,Lange P.Can GOLD stage O provide information of prognosis value in COPD[].American Journal of Respiratory and Critical Care Medicine.2002
  • 5Plant PK,Elliott MW.Chronic obstructive pulmorary disease 9: management of ventilatory failure in COPD[].Thorax.2003
  • 6White AJ,Gompertz S,Stockley RA.Chronic obstructive pulmonary disease.6: the aetiology of exacerbations of chronic obstructive pulmonary disease[].Thorax.2003
  • 7Weiss ST,DeMeo DL,Postma DS.COPD: problems in diagnosis and measurement[].European Respiratory Journal.2003
  • 8Wouters EF.Management of severe COPD[].The Lancet.2004
  • 9Oga T,Nashimura K,Tsukimo M,Sato S,Hajiro T.Analysis of the factors to mortality in chronic obstructive pulmonary disease; role of exercise capacity and health status[].American Journal of Respiratory and Critical Care Medicine.2003
  • 10Cazzola M,Matera MG.Long-acting bronchodilators are the first-choice option for the treatment of stable COPD[].Chest.2004

同被引文献46

引证文献8

二级引证文献70

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部